Materials, fluid dynamics, and solid mechanics aspects of coronary artery stents: A state-of-the-art review

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 86, Issue 2, 2008, Pages 569-590

  Lewis, Gladius ^a  

^a University of Memphis   (United States)

Author keywords

Cardiovascular; Computational fluid dynamics; Finite element analysis; Vascular stents

Indexed keywords

CHEMOTHERAPY; CLADDING (COATING); DRUG DELIVERY; DRUG DOSAGE; DYNAMICS; FLUID DYNAMICS; FLUID MECHANICS; METALS; SPEED;

BLOOD STREAMS; CORONARY ARTERY (CA); CORONARY ARTERY DISEASE (CAD); CRITICAL REVIEW; DRUG-ELUTING STENT; GEOGRAPHIC LOCATIONS; IN-STENT RESTENOSIS (ISR); PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA); REVASCULARIZATION; SHARP INCREASE; SOLID MECHANICS;

MECHANICS;

ABCIXIMAB; ACETYLSALICYLIC ACID; ANGIOPEPTIN; BIOLIMUS; CLOPIDOGREL; DEXAMETHASONE; ECHINOMYCIN; EVEROLIMUS; FLUINDOSTATIN; GENISTEIN; HEPARIN; HIRUDIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MATRIX METALLOPROTEINASE INHIBITOR; MYCOPHENOLIC ACID; PACLITAXEL; PIMECROLIMUS; RAPAMYCIN; TACROLIMUS; THIENOPYRIDINE DERIVATIVE; TIROFIBAN; ZOTAROLIMUS;

BARE METAL STENT; CORONARY STENT; DRUG ELUTING STENT; ENCAPSULATION; HUMAN; NONHUMAN; RESTENOSIS; REVIEW; RISK; STENT; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; STENTS;

EID: 47949097245     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31028     Document Type: Review

References (274)

1. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-952.
2. American Heart Association. Heart and stroke statistics update. Dallas, TX: American Heart Association; 2007.
3. British Heart Foundation. Coronary Heart Diseases Statistics. London: British Heart Foundation; 2006.
4. Sirtori CR. HDL and the progress of atherosclerosis: New insights. Eur Heart J 2006;8 (Suppl F):F4-F9.
5. Wikipedia. Coronary heart disease. http://en.wikipedia.org/wiki/ Coronary_heart_disease.
6. Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation 2007;115:1464-1480.
7. Berry C, L'Allier PL, Gregoire J, Lesperance J, Levesque S, Ibrahim R, Tardif JC. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 2007;115:1851-1857.
8. Rihal CS, Raco DL. Gersh BJ. Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: Review of the evidence and methodological considerations. Circulation 2003;108:2439-2445.
9. Sigwart U, Puel J, Mirkovich V, Joffre F, Kappenberger L. Intravascualar stents to prevent occlusion and restenosis after transluminal angioplasty. N Eng J Med 1987;316:701-706.
10. Mueller RL, Sanborn TA. The history of interventional cardiology: Cardiac catheterization, angioplasty, and related interventions. Am Heart J 1995;129:146-172.
11. Rankin JM, Penn IM. Coronary stenting: A global perspective. Am Coll Cardiol Curr J Rev 1998: (Nov/Dec)22-25.
12. American Heart Association. Stent procedure. http://www.americcanheart. org/presenter.jhtml?identifier=4721
13. Schwartz RS, Henry TD Pathophysiology of coronary artery restenosis. Rev Cardiovasc Med 2002;3 (Suppl 5):S4-S9.
14. Sutton JM, Ellis SG, Roubin GS. Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturo-Roubin Intracoronary stent investigator group. Circulation 1994;89:1126-1137.
15. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den Heuvel P. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Eng J Med 1994;331:489-495.
16. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S, for The Stent Restenosis Study investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in patients with coronary artery disease. N Eng J Med 1994;331:496-501.
17. Schomig A, Neumann FJ, Kastrati A, Schühlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth E-M, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Eng J Med 1996;334:1084-1089.
18. Palmaz JC. Intravascular stents in the last and the next ten years. J Endovasc Therap 2004;11 (Suppl II):II-200-II-206.
19. Assali AR, Moustapha A, Sdringola S, Denktas AE, Willerson JT, Holmes DR, Jr, Smalling RW. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol 2006;98:729-733.
20. Schüllen H, Kastrati A, Mehilli J, Hausleiter J, Pache J, Dirschinger J, Schömig A. Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 2004;147:317-322.
21. Mattos MA, Hodgson KJ, Hurlbert SN, Henretta JP, Sternbach Y, Douglas MG, Mansour MA, Hood DB, Sumner DS. Vascular stents. Curr Prob Surg 1999;36:909-1053.
22. Peterson ED, Lansky AJ, Anstrom KJ. Evolving trends in interventional device use and outcomes: Results from the National Cardiovascular Network (NCN) database. Am Heart J 2000;139:198-207.
23. Kandzari DE, Tcheng JE, Zidar JP. Coronary artery stents: Evaluating new designs for contemporary percutaneous intervention. Catheter Cardiovasc Interv 2002;56:562-576.
24. Hoffmann R, Mintz GS, Dussaillant GR. Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996;94:1247-1254.
25. Popma JJ. Stent selection in clinical practice: Have clinical trials provided the evidence we need? Am Heart J 2001;142:378-380.
26. Mudra H, Regar E, Klauss V, Werner F, Henneke K-H, Sbarouni E, Theisen K. Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. Circulation 1997;95:363-370.
27. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Vimani R. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52.
28. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003;361:247-249.
29. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91:2995-3001.
30. Prati F, Di Mario C, Moussa I, Reiers B, Mallus MT, Parma A. In-stent neointimal proliferation correlates with the amount of residual plaque burden outside the stent: An intravascular ultrasound study. Circulation 1999;99:1011-1014.
31. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle E, McFadden EP. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998;31:1291-1298.
32. Hoffmann R, Mintz GS, Mehran R, Kent KM, Pichard AD, Satler LF. Tissue proliferation within and surrounding Palmaz-Schatz stents is dependent on the aggressiveness of stent implantation technique. Am J Cardiol 1999;83:1170-1174.
33. Zhou RH, Lee TS, Tsou TC, Rannou F, Li YS, Chien S, Shyy JYJ. Stent implantation activates Akt in the vessel wall role of mechanical stretch in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23:2015-2020.
34. Scott N. Restenois following implantation of bare metal coronary stents: Pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev 2006;58:358-376.
35. Serruys P, Daeman J. Late stent thrombosis: A nuisance in both bare metal and drug-eluting stents. Circulation 2007;115:1433-1439.
36. Holmes D, Kereiakes J, Laskey W, Colombo A, Ellis S, Henry T, Popma JJ, Serruys PWJC, Kimura T, Williams DO, Windecker S, Krucoff MW. Thrombosis and drug-eluting stents: An objective appraisal. J Am Coll Cardiol 2007;50:109-118.
37. Jaffe R, Strauss B. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives. J Am Coll Cardiol 2007;50:119-127.
38. Kaul S, Shah P, Diamond G. Current status and future directions in the controversy over stenting. J Am Coll Cardiol 2007;50:128-137.
39. Leon MB. Late thrombosis a concern with drug-eluting stents. J Interven Cardiol 2007;20:26-29.
40. Kernis SJ, Choen D, Reid K. Clinical outcomes associated with use of DES compared with bare-metal stents for primary percutaneous intervention. Am J Cardiol 2005;96:37-47.
41. Honda Y, Fitzgerald. Stent thrombosis: An issue revisited in a changing world. Circulation 2003;108:2-5.
42. Wenaweser P, Dorffler-Melly J, Imboden K. Stent thrombosis is associated with an impaired response to antiplatelet therapy. J Am Coll Cardiol 2005;45:1748-1752.
43. Serruys P, Emauelsson H, Giessen W, Lunn A, Kiemeney F, Macaya C, Rutsch W, Heyndrickx G, Suryapranata H, Legrand V, Goy JJ, Materne P, Bonnier H, Morice M-C, Fajadet J, Belardi J, Colombo A, Garcia E, Ruygrok P, de Jaegere P, Morel M-A. Herparin-coated Palmaz-Schatz stents in human coronary arteries. Circulation 1996;93:412-422.
44. Cosgrave J, Melzi G, Corbett S, Zoccai G, Agostoni P, Babic R, Airoldi F, Chieffo A, Sangiorgi GM, Montorfano M, Michev I, Carlino M, Colombo A. Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice. J Am Coll Cardiol 2007; 49:2320-2328.
45. Fajadet J, Wijns W, Laarman G, Kuck K, Ormiston J, Münzel M, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE, for the ENDEAVOR II investigators. Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114:798-806.
46. Beijk M, Piek J. Xience V everolimus-eluting coronary stent systems: A novel second generation drug-eluting stent. Expert Rev Med Devices 2007;4:11-21.
47. Grube E, Lutz B. A next generation drug-eluting stent for coronary artery disease. Exp Rev Med Devices 2006;3:731-741.
48. Marks DS, Ratko TA, Matuszewski KA, Oinonen MJ, Cummings JP. Clinical and financial impact of drug-eluting Stents: The US academic experience. J Am Coll Cardiol 2005;45 (Suppl A):73A. Abstract.
49. Winslow R, Matthews AW. How doctors are rethinking drug-coated stents. Wall Street J December 9-10, 2006; p A1, A10.
50. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
51. Iakovou I, Schmidt T, Bonizzoni E. Incidence, predictors, and outcome of thrombosis after successful implantation of DES. J Am Med Assoc 2005;293:2126-2130.
52. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabaté M, Escaned J, Bañuelos C, Fernández-Ortiz A, Macaya C. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005;45:954-959.
53. Anthony AB, Dharam JK, Thomas JH, Przemyslaw PB, Girish RM, Deepak LB. Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-1061.
54. McFadden EP, Stabile E, Regar E. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-1521.
55. Grines CL, Bonow RO, Casey DE, Gardner TJ, Lockhart PB, Moliterno DJ, O'Gara P, Whitlow P. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association. American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007;49:734-739.
56. Valgimigli M, Campo G, Arcozzi C, Malagutti P, Carletti R, Ferrari F, Barbieri D, Parrinello G, Percoco G, Ferrari R. Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa inhibitor infusion in patients with myocardial infarction. J Am Coll Cardiol 2007;50:138-145.
57. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es G-A, Steg PG, Morel M-a, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-2351.
58. Curfman GD, Morrissey S, Jarcho JA, Drazen JM. Drug-eluting coronary stents promise and uncertainty. N Engl J Med 2007;350:1059-1060.
59. Kastrati A, Schomig A. Drug-eluting stents: Is their future as bright as their past? J Am Coll Cardiol 2007;50:146-148.
60. Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G. Drug eluting stents: An updated meta-analysis of randomized controlled trials. Interv Cardiol Surg 2006;92:641-649.
61. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trails of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol 2006;98:375-382.
62. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: A meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-1061.
63. Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grillt R, Maresta A. Long-term safety and efficacy of drug-eluting stents: Two-year results of the REAL multicenter registry. Circulation 2007;115:3181-3188.
64. Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW. A pooled analysis of data comparing siroliumus-eluting stents with bare-metal stents. N Eng J Med 2007;356:989-997.
65. Mauri L, Hsieh W-h, Massaro JM, Ho KKL, D'Agostino, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Eng J Med 2007;356:1020-1029.
66. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB. Safety and efficacy of sirolimus and paclitaxel-eluting coronary stents. N Eng J Med 2007;356:998-1008.
67. Boyden TF, Nallamothu BK, Moscucci M, Chan PS, Grossman PM, Tsai TT, Chetcuti SJ, Bates ER, Gurm HS. Am J Cardiol 2007;99:1399-1402.
68. Kandzari D, Leon M, Popma J, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE, for the ENDEAVOR III investigators. Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: A randomized controlled trial. J Am Coll Cardiol 2006;48:2440-2447.
69. Moreno R, Fernandez C, Calvo L, Sanchez-Recalde A, Galeote G, Sanchez-Aquino R, Alfonso F, Macaya C, Lopez-Sendon JL. Meta-analysis comparing the effect of drug-eluting versus bare metal stents in risk of acute myocardial infarction during follow-up. Am J Cardiol 2007;99:621-625.
70. Delgado-Rodriguez M. Systematic reviews of meta-analyses: Applications and limitations. J Epidemiol Commun Health 2006;60:90-92.
71. Tada S, Tarbell JM How through internal elastic lamina affects shear stress on smooth muscle cells. Am J Physiol 2002;282:H576-H584.
72. Murata T, Hiro T, Fujii T, Yasumoto K, Murashige A, Kohno M, Yamada J, Miura T, Matsuzaki M. Impact of the cross-sectional geometry of the post-deployment coronary stent on in-stent neointimal hyperplasia. Circ J 2002;66:489-493.
73. Wieneke H, Dirsch O, Sawitowski T, Gu Y, Brauer H, Dahmen U. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Catheter Cardiovasc Interv 2003;60:399-407.
74. Szmitko PE, Fedak PW, Weisel RD, Stewart DJ, Kutryk MJB, Verma S. Endothelial progenitor cells: New hope for a broken heart. Circulation 2003; 107:3093-3100.
75. Nakayama Y, Masuda T. Development of a polymeric matrix methalloproteinase inhibitor as a bioactive stent coating material for prevention of restenosis. J Biomed Mater Res Part B: Appl Biomater 2007;80:260-267.
76. Johnson A. New generation of cardiac stents awaits FDA approval. Wall Street J March 8, 2007; p D1, D6.
77. Carter AJ, Lee DP, Suzuki T, Bailey L, Lansky A, Jones R, Virmani R. Experimental evaluation of a short transitional edge protection balloon for intracoronary stent deployment. Catheter Cardiovasc Interv 2000;51:112-119.
78. Squire JC. Dynamics of endovascular stent expansion. PhD Dissertation, Massachusetts Institute of Technology, Cambridge, MA; 2000.
79. Dussaillant GR, Mintz GS, Pichard AD, Kent KM, Satler LF, Popma JJ, Wong SC, Leon MB. Small stent size and intimai hyperplasia contribute to restenosis: A volumetric intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:720-724.
80. McClean DR, Eigler NL Stent design: Implications for restenosis. Rev Cardiovasc Med 2002;3 (Suppl 5):S16-S22.
81. Arakawa K, Isoda K, Sugiyabu Y, Fukuda M, Nishizawa K, Shibuya T, Nakamura H. Intimai proliferation after stenting reflected by increased stent-to-vessel cross-sectional area ratio: Serial intravascular ultrasound study. J Cardiol 1998;32:379-389.
82. Yoshitomi Y, Kojima S, Yano M, Sugi T, Matsumoto Y, Saotome M, Tanaka K, Endo M, Kuramochi M. Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents. Am Heart J 2001;142:445-451.
83. Hoffmann R, Mintz GS, Haager PK, Bozoglu T, Grube E, Gross M, Beythien C, Mudra H, vom Dahl J, Hanrath P. Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound. Am J Cardiol 2002;89:1360-1364.
84. Briguori C, Sarais C, Pagnotta P, Liistro F, Montorfano M, Chieffo A, Sgura F, Corvaja N, Albiero R, Stankovic G, Toutoutzas C, Bonizzoni E, Di Mario C, Colombo A. Instent restenosis in small coronary arteries. J Am Coll Cardiol 2002;40:403-409.
85. Lau KW, Johan A, Sigwart U, Hung JS. A stent is not just a stent: Stent construction and design do matter in its clinical performance. Singapore Med J 2004;45:305-312.
86. Takebayashi H, Mintz GS, Carlier SG, Kobayashi Y, Fujii K, Yasuda A, Costa RA, Moussa I, Dangas GD, Mehran R, Lansky AJ, Kreps E, Collins MB, Colombo A, Stone GW, Leon MB, Moses JW. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation 2004;110:3430-3434.
87. Windecker S, Meier B. All stents are not alike or is the difference in the eye of the observer only? Eur Heart J 2001;22:1973-1977.
88. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, Mario CD, Colombo A. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol 1999;34:651-659.
89. Ikari Y, Hara K, Tamura T, Saeki F, Yamaguchi T. Luminal loss and site of restenosis after Palmaz-Schatz coronary stent implantation. Am J Cardiol 1995;76:117-120.
90. Hofma SH, van der Giesen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, Ligthart JMR, van Essen D, de Feyter PJ, Serruys PW. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006;27:166-170.
91. Virmani R Farb A Guagliumi G, Kolodgie FD. Drug-eluting stents: Caution and concerns for long-term outcome. Coron Artery Dis 2004;15:313-318.
92. Tsujino I, Ako J, Honda Y. Summary expert opinion on drug delivery. Exp Opin 2007;4:287-295.
93. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Ratsch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD. Hypersensitivity cases associated with drug-eluting stents: A review of available case from Research on the Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol 2006;47:175-181.
94. Silverman ME. Coronary-artery stents: Letter to the editor. N Engl J Med 2006;354:2076-2077.
95. Erne P, Schier M, Resink TJ. The road to bioabsorbable stents: Clinical reality? Cardiovasc Intervent Radiol 2006;29:11-16.
96. Barlis P, Tanigawa J, Di Mario C. Coronary bioabsorable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings. Eur Heart J 2007;28:2319.
97. Erbel R, Di Mario C, Bartunek J, Bonnier J, Bruyne B, Eberli F, Erne P, Haude M, Heublein B, Horrigan M, Ilsley C, Böse D, Koolen J, Lüscher TF, Weissman N, Waksman R. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: A prospective, non-randomised multicentre trial. Lancet 2007; 369:1869-1875.
98. Serruys P. Fourth Annual American College of Cardiology International Lecture: A journey in the interventional field. J Am Coll Cardiol 2006;47:1754-1768.
99. Zilberman M, Eberhart R. Drug-eluting bioresorbable stents for various applications. Ann Rev Biomed Eng 2006;8:153-180.
100. Ormiston J, Webster MWI. First-in-human implantation of a fully bioabsorbable drug-eluting stent: The BVS poly-L-lactic acid everolimus-eluting coronary stent. Cather Cardiovasc Interv 2006;69:128-131.
101. Tanimoto S, Serruys P, Thuesen L, Dudek D, de Bruyne BR, Chevalier B, Ormiston JA. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everlimous-eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials. Catheter Cardiovas Interv 2007;70:515-523.
102. Waksman R. Biodegradable stents: They do their job and disappear. J Inv Cardiol 2006;18:70-74.
103. Ormiston J, Webster M. Absorbable coronary stents. Lancet 2007;369:1839-1840.
104. Herrmann R, Schmidmaier G, Markel B, Resch A, Hahnel I, Stemberger A, Alt E. Antithrombogenic coating of stents using a biodegradable drug delivery technology. Thromb Haemost 1999;82:51-57.
105. Griffiths H, Peeters P, Verbist J, Bosiers M, Deloose K, Heublien B, Rohde R, Kasese V, Ilsley C, Mario C. Future devices: Bioabsorbable stents. Br J Cardiol 2004;11:AIC 80-AIC 84.
106. Whittaker DR, Fillinger MF. The engineering of endovascular stent technology: A review. Vasc Endovasc Surg 2006;40:85-94.
107. Alp NJ, Alt ZA, Channon KM. Models for study coronary artery stenting. Drug Discovery Today Dis Models 2006;3:297-303.
108. Mani G, Feldman MD, Patel D, Agrawal M. Coronary stents: A materials perspective. Biomaterials 2007;28:1689-1710.
109. Ramcharitar S, Vaina S, Serruys PW. The next generation of drug-eluting stents: What's on the horizon? Am J Cardiovasc Drugs 2007;7:81-93.
110. Hara H, Nakamura M, Palmaz J, Schwartz R. Role of stent design and coatings on restenosis and thrombosis. Adv Drug Deliv Rev 2006;58:377-386.
111. Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 2006;58:387-401.
112. Yang C, Burt H. Drug-eluting stents: Factors governing local pharmacokinetics. Adv Drug Deliv Rev 2006;58:402-411.
113. Venkatraman S, Boey F. Release profiles in drug-eluting stents: Issues and uncertainties. J Control Release 2007;120:149-160.
114. Luscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications. Circulation 2007;115:1051-1058.
115. Duraiswamy N, Schoephoerster RT, Moreno MR, Moore JE Jr. Stented artery flow patterns and the effects on the artery wall. Ann Rev Fluid Mech 2007;39:357-382.
116. Moore J, Berry J. Fluid and solid mechanical implications of vascular stenting. Ann Biomed Eng 2002;30:498-508.
117. Tung R, Kaul S, Diamond GA, Shah PK. Narrative review: Drug-eluting stents for the management of restenosis: A critical appraisal of the evidence. Ann Intern Med 2006;144:913-919.
118. Raka SG, Dreyfus GD. Efficapy and safety of drug-eluting stents: Current best available evidence. J Cardiac Surg 2006;21:605-612.
119. Serruys PW, Kutryk MJB, Ong ATL. Coronary-artery stents. N Engl J Med 2006;354:483-495.
120. Ray GM, Nawarskas JJ, Frishman WH. The paclitaxel-eluting stent in percutaneous coronary intervention. II. Compartson with the sirolimus-eluting stent, economics, and unanswered questions. Cardiol Rev 2006;14:143-150.
121. Groeneveld P, Suh J, Matta M. The costs and quality-of-life outcomes of drug-eluting coronary stents: A systematic review. J Interv Cardiol 2007;20:1-9.
122. Ryan J, Cohen D. Are drug-eluting stents cost-effective? It depends on whom you ask. Circulation 2006;114:1736-1744.
123. Eisenberg M. Drug-eluting stents: The price is not right. Circulation 2006;114:1745-1754.
124. Koster R, Sommerauer M, Kahler J, Baldus S, Meinertz T, Hamm CW. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet 2000;356(9245):1895-1857.
125. Herman RA, Rybnikar A, Resch A, Marki B, Alt E, Stemberger A. Thrombogeniciity of stainless steel coronary stents with a completely gold coated surface. J Am Coll Cardiol 1998;31(Suppl):413A.
126. Mario CD, Grube E, Nisanci Y, Reifart N, Colombo A, Rodermann J. MOONLIGHT: A controlled registry of an iridium oxide-coated stent with angiographic follow-up. Int J Cardiol 2004;95:329-331.
127. Kalnins U, Erglis A, Dinne I, Kumsars I, Jegere S. Clinical outcomes of silicon carbide coated stents in patients with coronary artery disease. Med Sci Monitor 2002;8:116-120.
128. Unverdorben M, Sattler K, Degenhardt R, Fries R, Abt B, Wagner E. Comparison of silicon carbide coated stent versus a noncoated stent in humans: The Tenax-versus Nir-stent study. J Interv Cardiol 2003;16:325-333.
129. Tanajura LF, Abizaid AA, Feres F, Pinto I, Mattos L, Staico R. Randomized intravascular ultrasound comparison between patients that underwent amorphous hydrogenated silicon-carbide coated stent deployment versus uncoated stent. J Am Coll Cardiol Abstr Angiogr Interv Cardiol 2003:58A.
130. Zheng H, Barragan P, Corcos T. Clinical experience with a biocompatible phosphorylchloline-coated coronary stent. J Invas Cardiol 1999;11:608-614.
131. Liu X, Huang Y, Hanet C, Vandormael M, Legrand V, Dens J. Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): A first-in-human multicenter pilot trial. Catheter Cardiovasc Interv 2003;60:172-178.
132. Kipshidze N, Leon M, Tsapenko M, Falotico R, Kopia G, Moses J. Update on sirolimus drug-eluting stents. Curr Pharm Des 2004;10:337-348.
133. Stone G, Ellis S, Cox D, Hermiller J, O'Shaughnessy C, Mann J, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, for the TAXUS-IV investigators. One-year clinical results with slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004;109:1942-1947.
134. Gershlick A, Scheerder I, Chevalier B. Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: The European evaluation of pacliaxel eluting stent (ELUTES) trial. Circulation 2004;109:487-493.
135. Stöver M, Renke-Gluszko M, Schratzenstaller T, Will J, Klink N, Behnisch B, Kastrati A, Wessely R, Hausleiter J, Schömig A, Wintermantel E. Microstructuring of stainless steel implants by electrochemical etching. J Mater Sci 2006;41:5569-5575.
136. Rettig R, Kunze J, Stover M, Wintermantel E, Virtanen S. Corrosion resistance studies on grain-boundary etched drug-eluting stents. J Mater Sci Mater Med 2007;18:1377-1387.
137. Wu SL, Chu PK, Liu XM, Ho JPY, Chu CL, Tjong SC, Yeung KWK, Lu WW, Cheung KMC, Luk KDK. Surface characteristics, mechanical properties, and cytocompatibiliity of oxygen plasma-implanted porous nickel titanium shape memory alloy. J Biomed Mater Res A 2006;79:139-146.
138. Tadic D, Beckmann F, Donath T, Epple M. Comparison of different methods for the preparation of porous bone substitution materials and structural investigations by synchrotron MU-computer tomography. Materialwiss Werkst 2004;35:240-244.
139. Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am Heart J 2003;145:739-741.
140. Clarke B, Carroll W, Rochev Y, Hynes M, Bradley D, Plumley D. Influence of nitinol wire surface treatment on oxide thickness and composition and its subsequent effect on corrosion resistance and nickel ion release. J Biomed Mater Res A 2006;79:61-70.
141. Gutensohn K, Beythien C, Bau J, Fenner T, Grewe P, Koester R. In-vitro analyses of diamond-like carbon coated stents. Reduction of metal ion release, platelet activation, and thrombogenicity. Thromb Res 2000;99:577-585.
142. McGee MP, Teuschler H, Liang J. Electrostatic interactions during activation of coagulation factor IX via the tissue factor pathway: Effect of univalent salts. Biochim Biophys Acta 1999;1453:239-253.
143. Shih CC, Shih CM, Chou KY, Lin SJ, Su YY. Stability of passivated 316L stainless steel oxide films for cardiovascular stents. J Biomed Mater Res A 2007;80:861-873.
144. Hasebe T, Shimada A, Suzuki T, Matsuoka Y, Saito T, Yohena S, Kamijo A, Shiraga N, Higuchi M, Kimura K, Yoshimura H, Kuribayashi S. Fluorinated diamond-like carbon as antithrombogenic coating for blood-contacting devices. J Biomed Mater Res A 2006;76:86-94.
145. Tepe G, Schmehl J, Wendel HP, Schaffner S, Heller S, Gianotti M, Claussen CD, Duda SH. Reduced thrombogenicity of nitinol stents-in vitro evaluation of different surface modifications and coatings. Biomaterials 2006;27:643-650.
146. Gunatillake PA, Martin DJ, Meijs GF, McCarthy SJ, Adhikari R. Designing biostable polyurethane elastomers for biomedical implants. Aust J Chem 2005;56:545-557.
147. Okamoto E, Couse T, De Leon H, Vinten-Johansen J, Goodman RB, Scott NA, Wilcox J. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 2001;104:2228-2235.
148. Lee YK, Park JH, Moon HT, Lee DY, Yun JH, Byun Y. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer. Biomaterials 2007;28:1523-1530.
149. Nakayama Y, Masuda T. Development of a polymeric matrix methalloproteinase inhibitor as a bioactive stent coating material for prevention of restenosis. J Biomed Mater Res Part B Appl Biomater 2007;80:260-267.
150. Wu B, Gerlitz B, Grinnell B, Meyerhoff M. Polymeric coatings that mimic the endothelium: Combining nitric oxide release with surface-bound active thrombomodulin and heparin. Biomaterials 2007;28:4047-4055.
151. Kipshidze N, Dangas G, Tsapenko M, Moses J, Leon MB, Kutryk M, Serruys P. Role of the endothelium in modulating neointimal formation: Vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions. J Am Coll Cardiol 2004;44:733-739.
152. Aoki J, Serruys PW, van Beusekom H, Ong ATL, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, Kutryk MJB. Endothelial progenitor cell capture by stents coated with antibody against CD34: The HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) registry. J Am Coll Cardiol 2005;45:1574-1579.
153. Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seltz B, Kapurniotu A, Kwok C, Dewor M, Bosserhoff AK, Bernhagen J, Hanrath P, Hoffmann R, Weber C. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J Am Coll Cardiol 2006;47:1786-1795.
154. Joner M, Farb A, Cheng Q, Finn AV, Acampado E, Burke AP, Skorjia K, Creighton W, Kolodgie FD, Gold HK, Virmani R. Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transformation growth factor-β and MCP-1. Arterioscler Thromb Vascul Biol 2007;27:182-189.
155. Walter DH, Cejna M, Diaz-Sandoval L, Willis S, Kirkwood L, Stratford PW, Tietz AB, Kirchmair R, Silver M, Curry C, Wecker A, Yoon Y-S, Heidenreich R, Hanley A, Kearney M, Tio FO, Kuenzler P, Isner JM, Losordo DW. Local gene transfer for ph VEGF-2 plasmid by gene-eluting stents: An alternative strategy for inhibition of restenosis. Circulation 2004;110:36-45.
156. Kipshidze NN, Iverson P, Kim H-S, Yiazdi H, Dangas G, Seaborn R, New G, Tio F, Waksman R, Mehran R, Tsapenko M, Stone GW, Roubin GS, Iyer S, Leon MB, Moses JW. Advanced c-myc antisense (AVI-4126)-eluting phosphorylcholine-coated stent implantation is associated with complete vascular healing and reduced neointimal formation in the porcine coronary restnosis model. Catheter Cardiovasc Interv 2004;61:518-527.
157. Hausleiter J, Kastrati A, Wessely R. Dose-finding study with a novel drug eluting system with the use of an on-site, polymer-free coating. J Am Coll Cardiol 2005;45:44A.
158. Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T, Graf I, Renke-Gluszko M, Behnisch B, Dirschinger J, Wintermantel E, Schömig A, for the investigators of the Individualizable Drug-Eluting Stent System to Abrogate Restenosis Project. Prevention of restenosis by a novel drug eluting stent system with a dose-adjustable, polymer-free on-site stent coating. Eur Heart J 2005;26:1475-1481.
159. Anon. MIV Therapeutics announces start of clinical trial marking first ever human implantation of a hydroxyapatite coated stent. Healthcare Sales Marketing Network NewsFeed May 31, 2007. pp 1-2.
160. Nguyen K, Shaikh N, Shukla K, Su S, Eberhart R, Tang L. Molecular responses of vascular smooth muscle cells and phagocytes to curcumin-eluting bioresorable stent materials. Biomaterials 2004;25:5333-5346.
161. Kong D, Park EJ, Stephen AG, Calvani M, Cardellina JH, Monks A, Fisher RJ, Robert H, Shoemaker RJ, Melillo G. Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity. Cancer Res 2005;65:9047-9055.
162. Yeung AC, Tsao P. Statin therapy: Beyond cholesterol lowering and anti-inflammatory effects. Circulation 2002;105:2937-2938.
163. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850.
164. McGillicuddy FC, Lynch I, Rochev YA, Burke M, Dawson KA, Gallagher WM, Keenan AK. Novel "plum pudding" gels as potential drug-eluting stent coatings: Controlled release of fluvastatin. J Biomed Mater Res A 2006;79:923-933.
165. Liu X, Huang Y, Hanet C, Vandormael M, Legrand V, Dens J. Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): A first-in-human multicenter pilot trial. Catheter Cardiovasc Interv 2003;60:172-178.
166. Abizaid A, Albertal M, Ormiston J, Londero H, Ruygrok P, Seixas AC, Feres F, Mattos LA, Staico R, Silva RL, Webster M, Stewart J, Paoletti F, Kataoka T, Fitzgerald P, Sousa A, Sousa JE. IMPACT trial: Angiographic and intravascular ultrasound observations of the first human experience with mycophenolic acid-eluting polymer stent system. Catheter Cardiovasc Interv 2005;66:491-495.
167. Daemen J, Serruys PW. Drug-eluting stent update 2007. I. A survey of current and future generation drug-eluting stents: Meaningful advances or more of the same? Circulation 2007;116:316-328.
168. Sternberg K, Kramer S, Nischan C, Grabow N, Langer T, Hennighausen G, Schmitz K-P. In vitro study of drug-eluting stent coatings based on poly(L-lactide) incorporating cyclosporine A - Drug release, polymer degradation and mechanical integrity. J Mater Sci Mat Med 2007;18:1423-1432.
169. Zilberman M, Sofer M. A mathematical model for predicting controlled release of bioactive agents from compositee fiber structures. J Biomed Mater Res A 2007;80:679-686.
170. Kraitzer A, Zilberman M. Paclitaxel-loaded composite fibers: Microstructure and emulsion stability. J Biomed Mater Res A 2007;81:427-436.
171. Zilberman M, Kraitzer A. Paclitaxel-eluting composite fibers: Drug release and tensile mechanical properties. J Biomed Mater Res A 2008;84:313-323.
172. Zilberman M. Novel composite fiber structures to provide drug/protein delivery for medical implants and tissue regeneration. Acta Biomaterialia 2007;3:51-57.
173. Trigwell S, De S, Sharma R, Mazumder MK, Mehta JL. Structural evaluation of radially expandable cardiovascular stents encased in a polyurethane film. J Biomed Mater Res Part B: Appl Biomater 2006;76:241-250.
174. Johnson A. J&J stent failure hurts standing in development of heart devices. Wall Street J May 8, 2007; p A3.
175. Ansett T. Johnson & Johnson stent trial flops. Wall Street J The Evening Wrap May 7, 2007.
176. Robaina S, Iayachandran B, He Y, Frank A, Moore J. Platelet adhesion to stimulated stented surfaces. J Endovasc Therapy 2003;10:978-986.
177. Walsh PW, Berkani F, Frank A, Moore JE Jr. Endothelial cell regrowth is affected by stent geometry under physiological flow conditions. In: International Symposium on Endovascular Therapy, Miami Beach, FL, 2002.
178. Whitcher FD. Simulation of in vivo loading conditions of Nitinol vascular stent structures. Comput Struct 1997;64:1005-1011.
179. Glenn R. Accelerated pulsitile fatigue testing of Ni Ti coronary stents. In: Second International Conference on Shape Memory and Superelastic Technologies, Pacific Grove, CA; 1997. pp 585-590.
180. Raamachandran J, Jayavenka . Modeling of stents exhibiting negative Poisson's ratio effect. Comput Meth Biomech Biomed Eng 2007;10:245-255.
181. Etave F, Finet G, Boivin M, Boyer JC, Rioufol G, Thollet G. Mechanical properties of coronary stents determined by using the finite element analysis. J Biomech 2001;34:1065-1075.
182. Migliavacca F, Petrini L, Colombo M, Auricchio F, Pietrabissa R. A predictive study of the mechanical behavior of coronary stents by computer modeling. Med Eng Phys 2005;27:13-18.
183. Mori K, Saito T. Effects of stent structure on stent flexibility. Ann Biomed Eng 2005;33:733-742.
184. Hall GJ, Kasper EP. Comparison of element technologies for modeling stent expansion. ASME J Biomech Eng 2006;128:751-756.
185. Donnelly EW, Bruzzi MS, Connolley T, McHugh PE. Finite element comparison of performance related characteristics of balloon-expandable stents. Comput Meth Biomech Biomed Eng 2007;10:103-110.
186. Chua SND, MacDonald BJ, Hashmi MSJ. Finite element simulation of stent and balloon interaction. J Mater Process Technol 2003;143:591-597.
187. Wang WQ, Liang DK, Yang DZ, Qi M. Analysis of the transient expansion behavior and design optimization of coronary stents by finite element method. J Biomech 2006;39:21-32.
188. Kwek TC, Yuan Q, Teo EC, Tony YJH, Guan KW. Design optimization of coronary stent by FEA. J Am Soc Artif Intern Organs 2000;46:201-217.
189. Barakat A, Cheng E. Numerical simulation of fluid mechanical disturbance induced by intravascular stents. In: Proceedings of the International Conference on Mechanics in Medicine and Biology-11, April 2-5, 2000, Maui, HI.
190. Seo T, Schachter L, Barakat A. Computational study of fluid mechanical disturbance induced by endovascular stents. Ann Biomed Eng 2005;33:444-456.
191. Berry JL, Santamarina A, Moore JE, Roychowdhury S, Routh WD. Experimental and computational flow evaluation of coronary stents. Ann Biomed Eng 2000;28:386-393.
192. Papaioannou T, Christofidis CC, Mathioulakis DS, Stefanadi CI. A novel design of a noncylindric stent with beneficial effects on flow characteristics: An experimental and numerical flow study in an axisymmetric arterial model with sequential mild stenoses. Artif Organ 2007;31:627-638.
193. LaDisa JF, Hettrick DA, Olson LE, Guler I, Gross ER, Kress TT, Kersten JR, Warltier DC, Pagel PS. Stent implantation alters coronary artery hemodynamics and wall shear stress during maximal vasodilation. J Appl Physiol 2002;93:1939-946.
194. Bernard N, Coisne D, Perrault R. Experimental study of blood laminar flow through a stented artery. Proc 23rd Ann Inter Conf IEEE 2001;1:83-85.
195. Yazdani SK, Moore JE Jr, Berry JL, Vlachos PP. DPIV measurements of flow disturbances in stented artery models: Adverse affects of compliance mismatch. J Biomech Eng 2004;126:559-566.
196. Wentzel JJ, Whelan DM, van der Giessen WJ, van Beusekom HMM, Andhyiswara I, Serruys PW, Slager CJ, Krams R. Coronary stent implantation changes 3-D vessel geometry and 3-D shear stress distribution. J Biomech 2000;33:1287-1295.
197. LaDisa JF, Guler L, Olson LE, Hettrick DA Kersten JR, Waltier C. Three-dimensional computational fluid dynamics modeling of alterations in coronary wall shear stress produced by stent implantation. Ann Biomed Eng 2003;31:972-980.
198. LaDisa JF Jr, Olson LE, Guler Im Hettrick DA, Audi SH, Kersten JR, Warltier DC, Pagel PS. Stent design properties and deployment ratio influence indexes of wall shear stress: A three-dimensional computational fluid dynamics investigation within a normal artery. J Appl Physiol 2004;97:424-430.
199. LaDisa JF, Olson LE, Guler I, Hettrick DA, Kersten JR, Warltier DC, Pagel PS. Circumferential vascular deformation after stent implantation alters wall stress evaluated with time-dependent 3D computational fluid dynamics models. J Appl Physiol 2005;98:947-957.
200. LaDisa JF Jr, Olson LE, Douglas HA, Warltier DC, Kersten JR, Pagel PS. Alterations in regional vascular geometry produced by theoretical stent implantation influence distributions of wall shear stress: Analysis of a curved coronary artery using 3D computational fluid dynamics modeling. Biomed Eng Online 2006:1-11. DOI: 10.1186/1475-925X-5-40.
201. Wentzel JJ, Krams R, Schuurbiers JCH, Oomen JA, Kloet J, van der Giessen WJ, Serruys PW, Slager CJ. Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries. Circulation 2001;103:1740-1745.
202. Rajamohan D, Banerjee R, Back L, Ibrahim A, Jog M. Developing pulsatile flow in a deployed coronary stent. ASME J Biomech Eng 2006;128:347-359.
203. He Y, Duraiswamy N, Frank AD, Moore JE Jr. Blood flow in stented arteries: A parametric comparison of strut design patterns in three dimensions. ASME J Biomech Eng 2005;127:637-647.
204. Deplano V, Bertolotti C, Barragan P. Three-dimensional numerical simulations of physiological flows in a stented coronary bifurcation. Med Biol Eng Comput 2004;42:650-659.
205. Feldman CL, Kinlay S, Coskun AU, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Popma JJ, Kuntz RE, Stone PH. In-vivo prediction of outward remodeling in native portions of stented coronary arteries associated with sites of high endothelial shear stress at the time of deployment. J Am Coll Cardiol 2002;39 (Suppl 1):247.
206. LaDisa JF, Olson LE, Hettrick DA, Warltier DC, Kersten JR, Pagel PS. Axial stent strut angle influences wall shear stress after stent implantation: Analysis using 3D computational fluid dynamics models of stent foreshortening. Biomed Eng Online 2005:1-10. DOI: 10.1186/1475-925X-4-59.
207. Gijsen FJH, Allante E, Van de Vosse FN, Janssen JD. The influence of the non-Newtonian properties of blood on the flow in large arteries: Unsteady flow in a 90 degree curved tube. J Biomech 1999;32:705-713.
208. Chein S, Usami S, Taylor J, Lundberg L, Gergersem MI. Effects of hematocrit and plasma proteins on human blood rheology at low shear rates. J Appl Physiol 1966;21:81-87.
209. Benard N, Perrault, Coisne D. Computational approach to estimating the effects of blood properties on changes in intra-stent flow. Ann Biomed Eng 2006;34:1259-1271.
210. Faik I, Mongrain R, Leask R, Rodes-Cabau J, Larose E, Bertrand O. Time-dependant 3D simulations of the hemodynamics in a stented coronary artery. Biomed Mater 2001;2:S28-S37.
211. Frank AO, Walsh PW, Moore JE Jr. Computational fluid dynamics and stent design. Artif Organs 2002;26:614-621.
212. Fox RW, McDonald AT. Introduction to Fluid Mechanics. New York: Wiley; 1992.
213. Moore JE, Robaina S, Jayachandran B, He Y, Schoephoerster R, Frank A. Platelet adhesion to simulated stented surfaces under physiologic flow conditions. Ann Biomed Eng 2001;29 (Suppl 1):S28.
214. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 1985;5:293-302.
215. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 1999;282:2035-2042.
216. Kute SM, Vorp DA. The effect of proximal artery flow on the hemodynamics at the distal anastomosis of a vascular bypass graft: Computational study. J Biomed Eng 2003;123:277-283.
217. Vernhet H, Juan JM, Demaria R, Olivia-lauraire M, Senac J, Dauzat M. Acute changes in aortic wall mechanical properties after stent placement in rabbits. J Vasc Interv Radiol 2000;11:634-638.
218. Murata T, Hiro T, Fujii T, Yasumoto K, Murashige A, Kohno M, Yamada J, Miura T, Matsuzaki M. Impact of the cross-sectional geometry of the post-deployment coronary stent on in-stent neointimal hyperplasia: An intravascular ultrasound study. Circulation J 2002;66:489-493.
219. Liu SQ, Goldman J. Role of blood shear stress in the regulation of vascular smooth muscle cell migration. IEEE Trans Biomed Eng 2001;48:474-483.
220. Ebeid MR. Balloon expandable stents for coarctation of the aorta: Review of current status and technical considerations. Images Pediatr Cardiol 2003;15:25-41.
221. Natarajan S, Moktarzadeh-Dehghan MR. A numerical and experimental study of periodic flow in a model of a corrugated vessel with application to stented arteries. Med Eng Phys 2000;22:555-566.
222. Cho YI, Back LH, Crawford DW, Cuffel RF. Experimental study of pulsatile and steady flow through a smooth tube and an atherosclerotic coronary artery casting of man. J Biomech 1983;16:933-946.
223. Qiu Y, Tarbell JM. Numerical simulation of pulsatile flow in a compliant curved tube model of a coronary artery. J Biomech Eng 2000;122:77-85.
224. Myers JG, Moore JA, Ojha M, Johnston KW, Ethier CR. Factors influencing blood flow patterns in the human right coronary artery. Ann Biomed Eng 2001;29:109-120.
225. Najarian S, Dargahi J, Firouzi F, Afsari J. Unsteady simulation of distal blood flow in an end-to-side anastomosed coronary bypass graft with stenosis. Bio-Med Mater Eng 2006;16:337-347.
226. Soulis JV, Giannoglou GD, Chatzizisis YS, Farmakis TM, Giannakoulas GA, Parcharidis GE, Louridas GE. Spatial and phasic oscillation of non-Newtonian wall shear stress in human left coronary artery bifurcation: An insight to atherogenesis. Coronary Artery Dis 2006;17:351-358.
227. Moore JE, Xu C, Glagov S, Zarins CK, Ku DN. Fluid wall shear stress measurements in a model of the human abdominal aorta: Oscillatory behavior and the relationship to atherosclerosis. Atherosclerosis 1994;110:225-240.
228. Johnston BM, Johnston PR, Corney S, Kilpatrick D. Non-Newtonian blood flow in human right coronary arteries: Transient simulations. J Biomech 2006;39:1116-1128.
229. Kalmar G, Hubner F, Voelker W, Hutzenlaub J, Teubner J, Poemer T, Suselbeck T, Borggrefe M, Haase KK. Radial force and wall apposition of balloon-expandable vascular stents in eccentric stenoses: An in vitro evaluation in a curved model. J Vasc Interv Radiol 2002;13:499-508.
230. Zhu H, Warner JJ, Gehrig TR, Friedman MH. Comparison of coronary artery dynamics pre- and post-stenting. J Biomech 2003;36:689-697.
231. Liao R, Green NE, Chen SYJ, Messenger JC, Hansgen AR, Groves BM, Carroll JD. Three-dimensional analysis of in vivo coronary stent-coronary artery interactions. Int J Cardiovasc Imaging 2004;20:305-313.
232. Rachev A, Manoach E, Berry J, Moore J. A model of stress-induced geometrical remodeling of vessel segments adjacent to stents and artery/graft anastomses. J Theor Biol 2000;206:429-443.
233. Brand M, Ryvkin M, Einav S, Slepvan L. The cardiociol stent-artery interaction. ASME J Biomech Eng 2005;127:337-344.
234. Prendergast PJ, Lally C, Daly S, Reid AJ, Lee TC, Quinn D, Dolan F. Analysis of prolapse in cardiovascular stents: A constitutive equation for vascular tissue and finite-element modeling. ASME J Biomech Eng 2003;125:692-699.
235. Auricchio F, Di Loreto M, Sacco E. Finite-element analysis of a stenotic artery revascularization through a stent insertion. Comput Meth Biomech Biomed Eng 2001;4:249-263.
236. Lally C, Dolan F, Prendergast PJ. Cardiovascular stent design and vessel stresses: A finite element analysis. J Biomech 2005;38:1574-1581.
237. Liang DK, Yang DZ, Qi M, Wang WQ. Finite element analysis of the implantation of a balloon-expandable stent in a stenosed artery. Int J Cardiol 2005;104:314-318.
238. Wu W, Wang W-Q, Yang D-Z, Qi M. Stent expansion in curved vessel and their interactions: A finite element analysis. J Biomech 2007;40:2580-2585.
239. Lally C, Prendergast PJ. Simulation of in-stent restenosis for the design of cardiovascular stents. In: Hozapfel GA, Ogden RW, editors. Mechanics of Biological Tissue. Berlin: Springer-Verlag; 2006. p 255-267.
240. Serruys P, Kutryk MJB. Handbook of Coronary Stents. London: Martin Dunitz; 1998.
241. Chen SL, Guo NS, Chen HD. The immediate elastic recoil of percutaneous coronary angiography ad intracoronary stent implantation. J Pract Radiol 2001;10:726-728.
242. Berry JL, Manoach E, Mekkaoui C, Rolland PH, Moore JE Jr. Rachev A. Hemodynamics and wall mechanics of a compliance matching stent: In vitro and in vivo analysis. J Vasc Interv Radiol 2002;13:97-105.
243. Bedoya J, Meyer CA, Timmins LH, Moreno MR, Moore JE Jr. Effect of stent design parameters on normal artery wall mechanics. ASME J Biomech Eng 2006;128:757-765.
244. Holzapfel GA, Schulze-Bauer CAJ, Stadler M. Mechanics of angioplasty: Wall, balloon and stent. In: Casey J, Bao G, editors.Mechanics in Biology. New York: The American Society of Mechanical Engineers; 2000. p 141-156. AMD-Vol. 242/BED-Vol. 46.
245. Holzapfel GA, Sommer G, Regitnig P. Anisotropic mechanical properties of tissue components in human atherosclerotic plaques. ASME J Biomech Eng 2004;126:657-665.
246. Holzapfel GA, Stadler M, Gasser TC. Changes in the mechanical environment of stenotic arteries during interaction with stents: Computational assessment of parametric stent designs. ASME J Biomech Eng 2005;127:166-180.
247. Holzapfel GA, Stadler M, Gasser TC. Towards a computational methodology for optimizing angioplasty treatments with stenting. In: Hozapfel GA, Ogden RW, editors. Mechanics of Biological Tissue. Berlin: Springer-Verlag; 2006. p 225-240.
248. Kiousis D, Gasser T, Holzapfel G. A numerical model to study the interaction of vascular stents with human atherosclerotic lesions. Ann Biomed Eng 2007;35:1857-1869.
249. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schattemann G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967.
250. Finkelstein A, McClean D, Kar S, Takizawa K, Varghese K, Baek N, Park K, Fishbein MC, Makkar R, Litvack F, Eigler NL. Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation 2003;107:777-784.
251. Sato S, Nakayama Y, Miura Y, Okamoto Y, Asano H, Ishibashi-Ueda H, Zhou Y-M, Hayashida K, Matsuhashi T, Seiji K, Sato A, Yamada T, Takahashi S, Ishibashi T. Development of self-expandable covered stents. J Biomed Mater Res Part B Appl Biomater 2007;83B:345-353.
252. Nguyen KT, Su S-H, Sheng A, Wawro D, Schwade ND, Brouse CF, Greilich PE, Tang L, Eberhart RC. In vitro hemocompatibility studies of drug-loaded poly-(L-lactic acid) fibers. Biomaterials 2003;24:5191-5201.
253. O'Flynn P, O'Sullivan G, Pandit A. Methods for three-dimensional geometric characterization of the arterial vasculature. Ann Biomed Eng 2007;35:1368-1381.
254. Wu HC, Shroff S, Carroll J. Stress analysis anatomically realistic coronary tree. Med Phys 2003;11:17-21.
255. LaDisa JF Jr, Olson LE, Ropella KM, Molthen RC, Haworth ST, Kersten JR, Warltier DC, Pagel PS. Microfocal x-ray computed tomography post-processing operations for optimizing reconstruction volumes of stented arteries during 3D computational fluid dynamics modeling. Comput Meth Program Biomed 2005;79:121-134.
256. Hron J, Madlik M. Fluid-structure interaction with applications in biomechanics. Nonlinear Anal Real World Appl 2007;8:1431-1458.
257. US Department of Health and Human Services. Guidance for the submission of research and marketing applications for interventional cardiology devices. Washington, DC: US Department of Health and Human Services; 1995.
258. Rieu R, Barragan P, Garitey V, Roquebert PO, Fuseri J, Commeau P, Sainsous J. Assessment of the trackability, flexibility, and conformability of coronary stents: A comparative analysis. Catheter Cardiovasc Interv 2003;59:496-503.
259. Connolley T, Nash D, Buffiere J, Shariff F, Mchugh P. X-ray micro-tomography of a coronary stent deployed in a model artery. Med Eng Phys 2007;29:1132-1141.
260. Lim CS, Yong J, Toh KM. Manufacturing and near-physiological testing of a biodegradable metallic coronary stent (BMCS). J Mech Med Biol 2007;7:89-100.
261. Chowdhury PS, Rmos RG. Coronary-stent fracture. N Engl J Med 2002;347:581.
262. Halkin A, Carlier S, Leon MB. Late incomplete lesion coverage following CYPHER stent deployment for diffuse right coronary artery stenosis. Heart 2004;90:e45.
263. Sianos G, Hofma S, Ligthart JMR. Stent fracture and restenosis in the drug-eluting stent era. Catheter Cardiovasc Interv 2004;61:111-116.
264. Min PK, Yoon YW, Kwon HM. Delayed strut fracture of sirolimus-eluting stent: A significant problem or an occasional observation? Int J Cardiol 2006;106:404-406.
265. Zaizen H, Tamura A, Miyamoto K, Nakaishi T, Kadota J. Complete fracture of sirolimus-eluting stent detected by multislice computed tomography. Int J Cardiol 2007;118:120-121.
266. Wilczynska J, Rdzanek A, Kochman J, Horszczaruk GJ, Pietrasik A, Opolski G. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery. Int J Cardiol 2007;118:126-127.
267. Hamilos MI, Papafaklis MI, Ligthart JM, Serruys PW, Sianos G. Stent fracture and restenosis of a paclitaxel-eluting stent. Hell J Cardiol 2005;46:439-442.
268. Kim E, Rha S, Want S, Suh S, Kim EJ, Rha S-W, Want SP, Suh SY, Choi CU, Kim JW, Park CG, Seo HS, Oh DJ. Coronary stent fracture and restonsis in the drug-eluting stent era: Do we have for clues management? Int J Cardiol 2007;120:417-419.
269. Petronio AS, De Carlo M, Branchitta G, Papini B, Ciabatti N, Gistri R, Cortese B, Gherarducci G, Barsotti A. Lesions in the left anterior descending artery. J Am Coll Cardiol 2007;49:539-546.
270. Costa MA, Sabate M, Angiolillo DJ. Intravascular ultrasound characterization of the "black hole" phenomenon after drug-eluting stent implantation. Am J Cardiol 2006;97:203-206.
271. Nakamura S, Muthusamy TS, Bae J-H, Cahyadi YH, Udayachalerm W, Tresukosol D. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions. Am J Cardiol 2005;95:161-166.
272. Lee CH, Low A, Lim J, Wong HB, Lim YT, Tan HC. CYPHER versus TAXUS stent for bifurcation lesions beyond 30 days-long-term follow-up results. Int J Cardiol 2007;117:422-424.
273. Lee CW, Suh J, Lee SW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries. Catheter Cardiovasc Interv 2006;69:821-825.
274. Philips PS, Alfonso F, Segovia J, Goicolea J, Hernandez R, Banuelos C, Fernandez-Ortiz A, Perez-Vizcayno MJ, Macaya C. Effects of Palmaz-Schatz stents on angled coronary arteries. Am J Cardiol 1997;79:191-193.